Treating sickle cell anemia

被引:51
作者
Tisdale, John F. [1 ]
Thein, Swee Lay [2 ]
Eaton, William A. [3 ]
机构
[1] NHLBI, Cellular & Mol Therapeut Branch, NIH, Bldg 10, Bethesda, MD 20892 USA
[2] NHLBI, Sickle Cell Branch, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NIDDK, Lab Chem Phys, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
DISEASE;
D O I
10.1126/science.aba3827
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:1198 / 1199
页数:2
相关论文
共 15 条
[1]   Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease [J].
Ataga, K. I. ;
Kutlar, A. ;
Kanter, J. ;
Liles, D. ;
Cancado, R. ;
Friedrisch, J. ;
Guthrie, T. H. ;
Knight-Madden, J. ;
Alvarez, O. A. ;
Gordeuk, V. R. ;
Gualandro, S. ;
Colella, M. P. ;
Smith, W. R. ;
Rollins, S. A. ;
Stocker, J. W. ;
Rother, R. P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (05) :429-439
[2]   CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells [J].
Dever, Daniel P. ;
Bak, Rasmus O. ;
Reinisch, Andreas ;
Camarena, Joab ;
Washington, Gabriel ;
Nicolas, Carmencita E. ;
Pavel-Dinu, Mara ;
Saxena, Nivi ;
Wilkens, Alec B. ;
Mantri, Sruthi ;
Uchida, Nobuko ;
Hendel, Ayal ;
Narla, Anupama ;
Majeti, Ravindra ;
Weinberg, Kenneth I. ;
Porteus, Matthew H. .
NATURE, 2016, 539 (7629) :384-389
[3]   Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study [J].
Eapen, Mary ;
Brazauskas, Ruta ;
Walters, Mark C. ;
Bernaudin, Francoise ;
Bo-Subait, Khalid ;
Fitzhugh, Courtney D. ;
Hankins, Jane S. ;
Kanter, Julie ;
Meerpohl, Joerg J. ;
Bolanos-Meade, Javier ;
Panepinto, Julie A. ;
Rondelli, Damiano ;
Shenoy, Shalini ;
Williamson, Joi ;
Woolford, Teonna L. ;
Gluckman, Eliane ;
Wagner, John E. ;
Tisdale, John F. .
LANCET HAEMATOLOGY, 2019, 6 (11) :E585-E596
[4]   Linus Pauling and sickle cell disease [J].
Eaton, WA .
BIOPHYSICAL CHEMISTRY, 2003, 100 (1-3) :109-116
[5]   Treating sickle cell disease by targeting HbS polymerization [J].
Eaton, William A. ;
Bunn, H. Franklin .
BLOOD, 2017, 129 (20) :2719-2726
[6]   Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies [J].
Magrin, Elisa ;
Miccio, Annarita ;
Cavazzana, Marina .
BLOOD, 2019, 134 (15) :1203-1213
[7]   Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin [J].
May, C ;
Rivella, S ;
Callegari, J ;
Heller, G ;
Gaensler, KML ;
Luzzatto, L ;
Sadelain, M .
NATURE, 2000, 406 (6791) :82-86
[8]   A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15 [J].
Menzel, Stephan ;
Garner, Chad ;
Gut, Ivo ;
Matsuda, Fumihiko ;
Yamaguchi, Masao ;
Heath, Simon ;
Foglio, Mario ;
Zelenika, Diana ;
Boland, Anne ;
Rooks, Helen ;
Best, Steve ;
Spector, Tim D. ;
Farrall, Martin ;
Lathrop, Mark ;
Thein, Swee Lay .
NATURE GENETICS, 2007, 39 (10) :1197-1199
[9]   Emerging Genetic Therapy for Sickle Cell Disease [J].
Orkin, Stuart H. ;
Bauer, Daniel E. .
ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 :257-271
[10]   HYDROXYUREA ENHANCES FETAL HEMOGLOBIN PRODUCTION IN SICKLE-CELL-ANEMIA [J].
PLATT, OS ;
ORKIN, SH ;
DOVER, G ;
BEARDSLEY, GP ;
MILLER, B ;
NATHAN, DG .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (02) :652-656